Breath test for lung cancer mutations

Scientists have shown that minimal genetic changes can be detected in vapour containing cells engineered to replicate early stage lung cancer. The findings could potentially be used to develop a breath test for lung cancer that is able to distinguish between different gene mutations.

Certain compounds detectable in the breath are known to be potential biomarkers for cancer, but it was not known is whether they reflected specific mutations. To study this, researchers from the University of Liverpool and the Technion – Israel Institute of Technology engineered bronchial airway cells to replicate early lung cancer, before analysing the vapour that had collected in the container used to grow them.

The researchers found that it was possible to distinguish between two different types of gene mutation that were present in the cells.

‘These findings tell us that it’s theoretically possible to develop a test that could diagnose early lung cancer in the breath of patients’, said Dr Mike Davies at the Roy Castle Lung Cancer Research Programme, who led the research.

The test could be used in early diagnostics to identify high-risk patients, explained the researchers. ‘It could also be used to help match patients to the right treatment by providing doctors with a snapshot of the genetic makeup of their individual tumour’, Dr Davies added.

Read the full, original story: Prototype lung cancer breath test checks for gene mutations

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Soybean Harvest in Cupped Hands
30 years of GMO farming: Defying cynics, we’ve had larger harvests, lower costs, and $385 billion in added global farmer income
Screenshot-2026-11-17-at-12.18.09-PM
Challenging glyphosate fear-mongering: Statewide Nebraska study finds no link between weedkiller use and non-Hodgkin lymphoma
Screenshot-2026-11-18-at-2.44.24-PM
Why should thousands of Americans die every year waiting for a kidney transplant? There’s an easy fix to this morbid reality
gut health
Health vs. hype on gut health: We are flooded by misinformation
measles
The grim human cost of the Trump—RFK Jr. measles-prevention failure: 16 times more cases than in 2024
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Low-Poly Climate Connections Infographic
Viewpoint: EU-backed climate “disinformation” crackdown—who polices what’s false?
Health vs
Health vs. Hype’s rocky debut: American Medical Association’s misinformation-debunking podcast platforms ‘leaky gut’ wellness crank 
Screenshot-2026-11-16-at-2.37.32-PM
30 years of GMO farming: Is the boom in glyphosate and glufosinate use harming the environment? Data show they’re the most sustainable choice
Gloved Hand Holding M-M-R Vaccine Vial
Viewpoint: The dangerous lie RFK Jr.-founded Children’s Health Defense is circulating to discredit one of medicine’s great breakthroughs: the MMR (measles-mumps-rubella) vaccine
BEMT Lotion for Freckled Skin
Burned by FDA bureaucracy: Why Americans waited decades for cancer-preventing sunscreen
Screenshot-2026-11-17-at-11.04.14-AM
There are more than 6,000 genetic disorders. For the first time, gene editing is making some treatable. Are we ready?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.